Increasing brain protein could be a treatment for obesity

January 20, 2023

  Drug target that revs up energy expenditure, reduces appetite identified Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu SAN ANTONIO (Jan. 20, 2023) — A drug that promotes energy expenditure in the body while suppressing appetite could be a powerful weight loss therapy. Researchers at The University of Texas Health Science Center at San Antonio, the Second […]




The Center for Brain Health (Opening in 2024-25)

January 20, 2023

With more than 50 studies, departments and centers, the Center for Brain Health at The University of Texas Health Science Center at San Antonio will be home to the institution’s many brain health initiatives. It will include an imaging suite and a non-oncology infusion suite for patient care and clinical trials.




The Center for Brain Health (Opening in 2024-25)

January 19, 2023

Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu With more than 50 studies, departments and centers, the Center for Brain Health at The University of Texas Health Science Center at San Antonio will be home to the institution’s many brain health initiatives. For a complete overview of these vital programs, visit https://advancingbrainhealth.org/. Recently, UT Health San Antonio received […]

Scanning of a human brain by X-rays


A new era in Alzheimer’s treatment

January 11, 2023

Statement from the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio about a timely topic in the news: The U.S. Food and Drug Administration on Friday, Jan. 6, 2023, approved lecanemab, a drug that targets the basic pathophysiology of Alzheimer’s disease. The FDA action is an “accelerated approval” of the […]


A new era in Alzheimer’s treatment

January 11, 2023

Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu Statement from the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio about a timely topic in the news: The U.S. Food and Drug Administration on Friday, Jan. 6, 2023, approved lecanemab, a drug that targets the basic pathophysiology of Alzheimer’s disease. The FDA action is […]

Alzheimer's written in wooden cubes on a table


Suri appointed as chairman of radiology in Long School of Medicine

January 10, 2023

Rajeev Suri, MD, MBA, has been named chairman of the Department of Radiology in the Joe R. and Teresa Lozano Long School of Medicine at The University of Texas Health Science Center at San Antonio. Suri, who previously served as interim chair of the Department of Radiology, was selected after an extensive national search. Robert […]